×

MAQTOX is collaborating with Telomir Pharmaceuticals to investigate the effects of Telomir-1 on telomere lengthening and its potential to treat age-related diseases. This research aims to explore how Telomir-1 can extend telomeres in human cells, particularly focusing on cell lines like MRC-5 fetal lung fibroblasts, HUVEC, and mesenchymal stem cells. The project also involves pre-clinical studies and data analysis to assess the safety and efficacy of Telomir-1 in addressing conditions linked to aging and inflammatory processes.

The key outcomes of this project will include:

  • Comprehensive pre-clinical data on the telomere extension process.
  • In-depth analysis of Telomir-1’s effect on aging-related markers.
  • Development of a potential therapeutic strategy targeting age-related conditions and chronic inflammation.

The project’s success could redefine the possibilities for extending healthy human lifespan and reversing age-associated diseases.

  • Client
    Telomir Pharmaceuticals, Inc.
  • Budget
    $5 million
  • Duration
    18 Month

Have Query ?